Status:

TERMINATED

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition

Lead Sponsor:

Johns Hopkins University

Conditions:

Bariatric Surgery

Eligibility:

All Genders

21-65 years

Phase:

PHASE2

Brief Summary

This study is being conducted to evaluate changes in sugar, metabolism, heart function and changes in body composition as patients lose weight following bariatric surgery. The investigators will compa...

Detailed Description

The study will also examine the response of the pancreas (the insulin-producing organ) to a sugar load, as well as to a hormone called Glucagon Like Peptide 1 (GLP-1), which is released from your gut ...

Eligibility Criteria

Inclusion

  • Male and female volunteers 21-65 years.
  • BMI \> 40.
  • Preoperative hematocrit level of at least 34% for women and 38% for men.
  • Postoperative hematocrit level of at least 34% for women and 36% for men.

Exclusion

  • Volunteers whose hematocrit level does not meet the above criteria.
  • Pregnant and or lactating females.

Key Trial Info

Start Date :

May 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT00686972

Start Date

May 1 2007

End Date

October 1 2010

Last Update

July 2 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, United States, 21224

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition | DecenTrialz